Erratum: A hypothesis: Hydrogen sulfide might be neuroprotective against subarachnoid hemorrhage induced brain injury (The Scientific World Journal (2014) 2014 (432318) DOI: 10.1155/2014/432318);A hypothesis: Hydrogen sulfide might be neuroprotective against subarachnoid hemorrhage induced brain injury

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Yu, Yong Peng ^a   Chi, Xiang Lin ^a   Liu, Li Jun ^b  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HYDROGEN SULFIDE; NITRIC OXIDE; NEUROPROTECTIVE AGENT;

ARTERY DIAMETER; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD BRAIN BARRIER; BLOOD FLOW; BRAIN INJURY; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM DISEASE; DRUG EFFECT; HISTOCOMPATIBILITY; HUMAN; HYPOTHESIS; INFLAMMATION; LEUKOCYTE ADHERENCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SUBARACHNOID HEMORRHAGE; VASCULAR TISSUE; ANIMAL; BRAIN INJURIES; COMPLICATION; DRUG EFFECTS; PHYSIOLOGY; VASODILATATION;

ANIMALS; BRAIN INJURIES; HUMANS; HYDROGEN SULFIDE; NEUROPROTECTIVE AGENTS; SUBARACHNOID HEMORRHAGE; VASODILATION;

EID: 84896996077     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2020/8364250     Document Type: Erratum

References (107)

1. Ndisang J. F., Tabien H. E. N., Wang R., Carbon monoxide and hypertension. Journal of Hypertension 2004 22 6 1057 1074 2-s2.0-2642537616 10.1097/00004872-200406000-00002 (Pubitemid 38720993)
2. 2S): a new antihypertensive drug? Medical Hypotheses 2009 73 3 445 447 2-s2.0-67649588308 10.1016/j.mehy.2009.03.030
3. Szabõ C., Hydrogen sulphide and its therapeutic potential. Nature Reviews Drug Discovery 2007 6 11 917 935 2-s2.0-35748959038 10.1038/nrd2425 (Pubitemid 350042399)
4. Fiorucci S., Antonelli E., Distrutti E., Rizzo G., Mencarelli A., Orlandi S., Zanardo R., Renga B., Di Sante M., Morelli A., Cirino G., Wallace J. L., Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 2005 129 4 1210 1224 2-s2.0-26844568431 10.1053/j.gastro.2005.07.060 (Pubitemid 41446861)
5. Kimura Y., Dargusch R., Schubert D., Kimura H., Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxidants and Redox Signaling 2006 8 3-4 661 670 2-s2.0-33646680757 10.1089/ars.2006.8.661 (Pubitemid 43741334)
6. Nicholson C. K., Calvert J. W., Hydrogen sulfide and ischemia-reperfusion injury. Pharmacological Research 2010 62 4 289 297 2-s2.0-77955269222 10.1016/j.phrs.2010.06.002
7. Shibuya N., Tanaka M., Yoshida M., Ogasawara Y., Togawa T., Ishii K., Kimura H., 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxidants and Redox Signaling 2009 11 4 703 714 2-s2.0-60749088329 10.1089/ars.2008.2253
8. Hosoki R., Matsuki N., Kimura H., The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochemical and Biophysical Research Communications 1997 237 3 527 531 2-s2.0-0031589557 10.1006/bbrc.1997.6878 (Pubitemid 27434718)
9. Chen P., Poddar R., Tipa E. V., Dibello P. M., Moravec C. D., Robinson K., Green R., Kruger W. D., Garrow T. A., Jacobsen D. W., Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Advances in Enzyme Regulation 1999 39 93 109 2-s2.0-0032864302 10.1016/S0065-2571(98)00029-6 (Pubitemid 29454872)
10. Li L., Moore P. K., Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends in Pharmacological Sciences 2008 29 2 84 90 2-s2.0-38749105788 10.1016/j.tips.2007.11.003
11. 2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2008 294 6 R1930 R1937 2-s2.0-47549089687 10.1152/ajpregu.00025.2008
12. Furne J., Saeed A., Levitt M. D., Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2008 295 5 R1479 R1485 2-s2.0-57349171934 10.1152/ajpregu.90566.2008
13. Levitt M. D., Abdel-Rehim M. S., Furne J., Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue. Antioxidants and Redox Signaling 2011 15 2 373 378 2-s2.0-79959515287 10.1089/ars.2010.3525
14. Abe K., Kimura H., The possible role of hydrogen sulfide as an endogenous neuromodulator. Journal of Neuroscience 1996 16 3 1066 1071 2-s2.0-0029876402 (Pubitemid 26140863)
15. Savage J. C., Gould D. H., Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography. Journal of Chromatography-Biomedical Applications 1990 526 2 540 545 2-s2.0-0025266258 10.1016/S0378-4347(00)82537-2 (Pubitemid 20111749)
16. Wang R., The gasotransmitter role of hydrogen sulfide. Antioxidants and Redox Signaling 2003 5 4 493 501 2-s2.0-0042763556 (Pubitemid 37087410)
17. Cheng Y., Ndisang J. F., Tang G., Cao K., Wang R., Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. The American Journal of Physiology-Heart and Circulatory Physiology 2004 287 5 H2316 H2323 2-s2.0-7244240892 10.1152/ajpheart.00331.2004 (Pubitemid 39430772)
18. Kubo S., Doe I., Kurokawa Y., Nishikawa H., Kawabata A., Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 2007 232 1-2 138 146 2-s2.0-33847128813 10.1016/j.tox.2006.12.023 (Pubitemid 46283181)
19. Kiss L., Deitch E. A., Szabó C., Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sciences 2008 83 17-18 589 594 2-s2.0-53249087745 10.1016/j.lfs.2008.08.006
20. Lee S. W., Cheng Y., Moore P. K., Bian J.-S., Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 2007 358 1142 1147 (Pubitemid 46829008)
21. Jia J. L., Liu Y.-H., Khin E. S. W., Bian J.-S., Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. The American Journal of Physiology-Cell Physiology 2008 295 5 C1261 C1270 2-s2.0-57349128456 10.1152/ajpcell.00195.2008 (Pubitemid 352790339)
22. Li L., Rose P., Moore P. K., Hydrogen sulfide and cell signaling. Annual Review of Pharmacology and Toxicology 2011 51 169 187 2-s2.0-79951980126 10.1146/annurev-pharmtox-010510-100505
23. Popov D., An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential. Archives of Physiology and Biochemistry 2013 119 189 194 10.3109/13813455.2013.803578
24. Stein A., Bailey S. M., Redox biology of hydrogen sulfide: implications for physiology, pathophysiology, and pharmacology. Redox Biology 2013 1 32 39 10.1016/j.redox.2012.11.006
25. Snijder P. M., de Boer R. A., Bos E. M., Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism. PLoS ONE 2013 8 e63291
26. Kimura H., Production and physiological effects of hydrogen sulfide. Antioxidants & Redox Signaling 2013 20 5 783 793
27. Du J. T., Li W., Yang J. Y., Tang C. S., Li Q., Jin H. F., Hydrogen sulfide is endogenously generated in rat skeletal muscle and exerts a protective effect against oxidative stress. Chinese Medical Journal 2013 126 930 936
28. Bos E. M., Wang R., Snijder P. M., Cystathionine γ -lyase protects against renal ischemia/reperfusion by modulating oxidative stress. Journal of the American Society of Nephrology 2013 24 759 770 10.1681/ASN.2012030268
29. Yin J., Tu C., Zhao J., Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats. Brain Research 2013 1491 188 196 10.1016/j.brainres.2012.10.046
30. Zhou J., Wu P. F., Wang F., Chen J. G., Targeting gaseous molecules to protect against cerebral ischaemic injury: mechanisms and prospects. Clinical and Experimental Pharmacology and Physiology 2012 39 566 576 10.1111/j.1440-1681.2011.05654.x
31. Han J., Chen Z. W., He G. W., Acetylcholine and sodium hydrosulfide-induced endothelium-dependent relaxation and hyperpolarization in cerebral vessels of global cerebral ischemia-reperfusion rat. Journal of Pharmacological Sciences 2013 121 318 326 10.1254/jphs.12277FP
32. Di Villa Bianca R. D., Sorrentino R., Coletta C., Mitidieri E., Rossi A., Vellecco V., Pinto A., Cirino G., Sorrentino R., Hydrogen sulfide-induced dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed. Journal of Pharmacology and Experimental Therapeutics 2011 337 1 59 64 2-s2.0-79953001973 10.1124/jpet.110.176016
33. Muzaffar S., Shukla N., Bond M., Newby A. C., Angelini G. D., Sparatore A., Del Soldato P., Jeremy J. Y., Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. Journal of Vascular Research 2008 45 6 521 528 2-s2.0-54249148441 10.1159/000129686
34. Bucci M., Papapetropoulos A., Vellecco V., Zhou Z., Pyriochou A., Roussos C., Roviezzo F., Brancaleone V., Cirino G., Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 10 1998 2004 2-s2.0-77957718685 10.1161/ATVBAHA.110. 209783
35. 2+ signalling in human vascular endothelial cells by hydrogen sulfide. Atherosclerosis 2010 209 2 374 380 2-s2.0-77950020469 10.1016/j.atherosclerosis.2009.10.004
36. Olson K. R., Dombkowski R. A., Russell M. J., Doellman M. M., Head S. K., Whitfield N. L., Madden J. A., Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. Journal of Experimental Biology 2006 209 20 4011 4023 2-s2.0-33749181930 10.1242/jeb.02480 (Pubitemid 44769370)
37. Bhatia M., Wong F. L., Fu D., Lau H. Y., Moochhala S. M., Moore P. K., Role of hydrogen sulfide in acute pancreatitis and associated lung injury. The FASEB Journal 2005 19 6 623 625 2-s2.0-16344392164 10.1096/fj.04-3023fje (Pubitemid 40471265)
38. Liu Y.-H., Bian J.-S., Bicarbonate-dependent effect of hydrogen sulfide on vascular contractility in rat aortic rings. The American Journal of Physiology-Cell Physiology 2010 299 4 C866 C872 2-s2.0-77957675701 10.1152/ajpcell.00105.2010
39. Osipov R. M., Robich M. P., Feng J., Chan V., Clements R. T., Deyo R. J., Szabo C., Sellke F. W., Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interactive Cardiovascular and Thoracic Surgery 2010 10 4 506 512 2-s2.0-77950666590 10.1510/icvts.2009.219535
40. Pluta R. M., Hansen-Schwartz J., Dreier J., Vajkoczy P., Macdonald R. L., Nishizawa S., Kasuya H., Wellman G., Keller E., Zauner A., Dorsch N., Clark J., Ono S., Kiris T., Leroux P., Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurological Research 2009 31 2 151 158 2-s2.0-62549125030 10.1179/174313209X393564
41. Alaraj A., Charbel F. T., Amin-Hanjani S., Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage. Neurological Research 2009 31 6 651 659 2-s2.0-68149183517 10.1179/174313209X382395
42. Friedrich V., Flores R., Muller A., Sehba F. A., Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage. Neuroscience 2010 165 3 968 975 2-s2.0-72749116618 10.1016/j.neuroscience.2009.10.038
43. Sehba F. A., Pluta R. M., Zhang J. H., Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Molecular Neurobiology 2011 43 1 27 40 2-s2.0-79951557739 10.1007/s12035-010-8155-z
44. Spallone A., Acqui M., Pastore F. S., Guidetti B., Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surgical Neurology 1987 27 3 253 258 2-s2.0-0023138063 (Pubitemid 17030015)
45. Sehba F. A., Bederson J. B., Nitric oxide in early brain injury after subarachnoid hemorrhage. Acta neurochirurgica. Supplement 2011 110 1 99 103 2-s2.0-79952278682
46. Vergouwen M. D. I., Ilodigwe D., MacDonald R. L., Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011 42 4 924 929 2-s2.0-79954911257 10.1161/STROKEAHA.110.597914
47. Bosche B., Graf R., Ernestus R.-I., Dohmen C., Reithmeier T., Brinker G., Strong A. J., Dreier J. P., Woitzik J., Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex. Annals of Neurology 2010 67 5 607 617 2-s2.0-77951716202 10.1002/ana.21943
48. Dreier J. P., Major S., Manning A., Woitzik J., Drenckhahn C., Steinbrink J., Tolias C., Oliveira-Ferreira A. I., Fabricius M., Hartings J. A., Vajkoczy P., Lauritzen M., Dirnagl U., Bohner G., Strong A. J., Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009 132 7 1866 1881 2-s2.0-67650089668 10.1093/brain/awp102
49. Pradilla G., Chaichana K. L., Hoang S., Huang J., Tamargo R. J., Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery Clinics of North America 2010 21 2 365 379 2-s2.0-77951039949 10.1016/j.nec.2009.10.008
50. Glick D., Barth S., Macleod K. F., Autophagy: cellular and molecular mechanisms. Journal of Pathology 2010 221 1 3 12 2-s2.0-77950994646 10.1002/path.2697
51. Wang Z., Shi X.-Y., Yin J., Zuo G., Zhang J., Chen G., Role of autophagy in early brain injury after experimental subarachnoid hemorrhage. Journal of Molecular Neuroscience 2012 46 1 192 202 2-s2.0-84858834658 10.1007/s12031-011- 9575-6
52. Liu C., Gao Y., Barrett J., Hu B., Autophagy and protein aggregation after brain ischemia. Journal of Neurochemistry 2010 115 1 68 78 2-s2.0-77956562189 10.1111/j.1471-4159.2010.06905.x
53. Zhang Y. B., Li S. X., Chen X. P., Autophagy is activated andmight protect neurons fromdegeneration after traumatic brain injury. Neuroscience Bulletin 2008 24 143 149 10.1007/s12264-008-1108-0 (Pubitemid 352020324)
54. Wagner F., Asfar P., Calzia E., Radermacher P., Szabó C., Bench-to-bedside review: hydrogen sulfide-the third gaseous transmitter: applications for critical care. Critical Care 2009 13 3 213 2-s2.0-70350452015
55. Mancardi D., Penna C., Merlino A., Del Soldato P., Wink D. A., Pagliaro P., Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochimica et Biophysica Acta 2009 1787 7 864 872 2-s2.0-67649289870 10.1016/j.bbabio.2009.03.005
56. 2S, a neuromodulator and smooth muscle relaxant. Nutrition Reviews 2004 62 9 348 353 2-s2.0-4644266615 10.1301/nr.2004.sept.348-353 (Pubitemid 39299136)
57. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. The American Journal of Physiology-Heart and Circulatory Physiology 2002 283 2 H474 H480 2-s2.0-0036073185 (Pubitemid 34790838)
58. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ -lyase. Science 2008 322 5901 587 590 2-s2.0-54949084607 10.1126/science.1162667
59. Daneshtalab N., Smeda J. S., Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke. Cardiovascular Research 2010 86 1 160 168 2-s2.0-77949409254 10.1093/cvr/cvp395
60. Bredt D. S., Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radical Research 1999 31 6 577 596 2-s2.0-0032740245
61. Kanu A., Whitfield J., Leffler C. W., Carbon monoxide contributes to hypotension-induced cerebrovascular vasodilation in piglets. The American Journal of Physiology-Heart and Circulatory Physiology 2006 291 5 H2409 H2414 2-s2.0-33751176492 10.1152/ajpheart.01368.2005
62. Zoccali C., Catalano C., Rastelli S., Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. Nephrology Dialysis Transplantation 2009 24 5 1394 1396 2-s2.0-65249109793 10.1093/ndt/gfp053
63. Fago A., Jensen F. B., Tota B., Feelisch M., Olson K. R., Helbo S., Lefevre S., Mancardi D., Palumbo A., Sandvik G. K., Skovgaard N., Integrating nitric oxide, nitrite and hydrogen sulfide signaling in the physiological adaptations to hypoxia: a comparative approach. Comparative Biochemistry and Physiology-A Molecular and Integrative Physiology 2012 162 1 1 6 2-s2.0-84858338051 10.1016/j.cbpa.2012.01.011
64. Moncada S., Palmer R. M. J., Higgs E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991 43 2 109 142 2-s2.0-0025883342
65. Plane F., Wiley K. E., Jeremy J. Y., Cohen R. A., Garland C. J., Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery. British Journal of Pharmacology 1998 123 7 1351 1358 2-s2.0-0031889189 10.1038/sj.bjp.0701746 (Pubitemid 28143135)
66. + channels in augmented relaxations to sodium nitroprusside induced by mexiletine in rat aortas. Anesthesiology 2000 92 3 813 820 2-s2.0-0034054122 (Pubitemid 30130184)
67. Toda N., Ayajiki K., Okamura T., Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacological Reviews 2009 61 1 62 97 2-s2.0-63849086007 10.1124/pr.108.000547
68. Martin W., Villani G. M., Jothianandan D., Furchgott R. F., Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. Journal of Pharmacology and Experimental Therapeutics 1985 232 3 708 716 2-s2.0-0021991915 (Pubitemid 15135858)
69. Toda N., Okamura T., The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacological Reviews 2003 55 2 271 324 2-s2.0-0038282995 10.1124/pr.55.2.3 (Pubitemid 36666049)
70. Iadecola C., Zhang F., Casey R., Nagayama M., Elizabeth Ross M., Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. Journal of Neuroscience 1997 17 23 9157 9164 2-s2.0-0030664096 (Pubitemid 27498443)
71. Vellimana A. K., Milner E., Azad T. D., Harries M. D., Zhou M.-L., Gidday J. M., Han B. H., Zipfel G. J., Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 2011 42 3 776 782 2-s2.0-79952072187 10.1161/STROKEAHA.110. 607200
72. Pluta R. M., Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurological Research 2006 28 7 730 737 2-s2.0-33750453069 10.1179/016164106X152052 (Pubitemid 44656099)
73. Sun B.-L., Zhang S.-M., Xia Z.-L., Yang M.-F., Yuan H., Zhang J., Xiu R.-J., L-arginine improves cerebral blood perfusion and vasomotion of microvessels following subarachnoid hemorrhage in rats. Clinical Hemorheology and Microcirculation 2003 29 3-4 391 400 2-s2.0-1642562621 (Pubitemid 38130412)
74. Ito Y., Isotani E., Mizuno Y., Azuma H., Hirakawa K., Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin. Journal of Cardiovascular Pharmacology 2000 35 1 45 50 2-s2.0-0033986233 10.1097/00005344-200001000-00006 (Pubitemid 30032893)
75. Cosby K., Partovi K. S., Crawford J. H., Patel R. P., Reiter C. D., Martyr S., Yang B. K., Waclawiw M. A., Zalos G., Xu X., Huang K. T., Shields H., Kim-Shapiro D. B., Schechter A. N., Cannon R. O. III, Gladwin M. T., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nature Medicine 2003 9 12 1498 1505 2-s2.0-10744220361 10.1038/nm954 (Pubitemid 38004777)
76. Pluta R. M., Dejam A., Grimes G., Gladwin M. T., Oldfield E. H., Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of the American Medical Association 2005 293 12 1477 1484 2-s2.0-15044344420 10.1001/jama.293.12.1477 (Pubitemid 40393292)
77. Dombkowski R. A., Russell M. J., Schulman A. A., Doellman M. M., Olson K. R., Vertebrate phylogeny of hydrogen sulfide vasoactivity. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2005 288 1 R243 R252 2-s2.0-11144302517 10.1152/ajpregu.00324.2004 (Pubitemid 40023936)
78. Whiteman M., Li L., Kostetski I., Chu S. H., Siau J. L., Bhatia M., Moore P. K., Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochemical and Biophysical Research Communications 2006 343 1 303 310 2-s2.0-33645102456 10.1016/j.bbrc.2006.02.154
79. Olson K. R., Whitfield N. L., Hydrogen sulfide and oxygen sensing in the cardiovascular system. Antioxidants and Redox Signaling 2010 12 10 1219 1234 2-s2.0-77950801465 10.1089/ars.2009.2921
80. Kram L., Grambow E., Mueller-Graf F., Sorg H., Vollmar B., The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases. Thrombosis Research 2013 132 e112 e117 10.1016/j.thromres.2013.07.010
81. 2+ homeostasis mediated by concomitantly produced nitric oxide via a novel synergistic pathway in exocrine pancreas. Antioxidants & Redox Signaling 2013 20 5 747 758
82. Chen Y.-H., Yao W.-Z., Geng B., Ding Y.-L., Lu M., Zhao M.-W., Tang C.-S., Endogenous hydrogen sulfide in patients with COPD. Chest 2005 128 5 3205 3211 2-s2.0-28244479039 10.1378/chest.128.5.3205 (Pubitemid 41699831)
83. Ishigami M., Hiraki K., Umemura K., Ogasawara Y., Ishii K., Kimura H., A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxidants and Redox Signaling 2009 11 2 205 214 2-s2.0-58149090827 10.1089/ars.2008.2132
84. Cunha T. M., Dal-Secco D., Verri W. A. Jr., Guerrero A. T., Souza G. R., Vieira S. M., Lotufo C. M., Neto A. F., Ferreira S. H., Cunha F. Q., Dual role of hydrogen sulfide in mechanical inflammatory hypernociception. European Journal of Pharmacology 2008 590 1- 127 135 2-s2.0-48049087189 10.1016/j.ejphar.2008.05.048
85. Liu Y.-Y., Sparatore A., Del Soldato P., Bian J.-S., ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β -induced cell cytotoxicity. Neurochemistry International 2011 58 5 591 598 2-s2.0-79952575528 10.1016/j.neuint.2011.01.023
86. Qu K., Lee S. W., Bian J. S., Low C.-M., Wong P. T.-H., Hydrogen sulfide: neurochemistry and neurobiology. Neurochemistry International 2008 52 1 155 165 2-s2.0-36849065800 10.1016/j.neuint.2007.05.016 (Pubitemid 350235691)
87. Hu L.-F., Lu M., Tiong C. X., Dawe G. S., Hu G., Bian J.-S., Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 2010 9 2 135 146 2-s2.0-77953262917 10.1111/j.1474-9726.2009.00543.x
88. Korczyn A. D., Vascular contribution to dementia in Parkinson's disease. Neurodegenerative Diseases 2010 7 1-3 127 130 2-s2.0-76749155735 10.1159/000285522
89. Zhang L.-M., Jiang C.-X., Liu D.-W., Hydrogen sulfide attenuates neuronal injury induced by vascular dementia via inhibiting apoptosis in rats. Neurochemical Research 2009 34 11 1984 1992 2-s2.0-70349604413 10.1007/s11064-009-0006-9
90. Hampel H., Amyloid-beta and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms. Journal of Alzheimer's Disease 2013 33 S79 S86
91. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W. F., Wolf P. A., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine 2002 346 7 476 483 2-s2.0-0037075257 10.1056/NEJMoa011613 (Pubitemid 34441738)
92. Tang X.-Q., Shen X.-T., Huang Y.-E., Ren Y.-K., Chen R.-Q., Hu B., He J.-Q., Yin W.-L., Xu J.-H., Jiang Z.-S., Hydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells. Neuroscience Research 2010 68 3 241 249 2-s2.0-77957662129 10.1016/j.neures.2010.07.2039
93. Whiteman M., Winyard P. G., Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Review of Clinical Pharmacology 2011 4 1 13 32 2-s2.0-78650485623 10.1586/ecp.10.134
94. Tan B. H., Wong P. T.-H., Bian J.-S., Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochemistry International 2010 56 1 3 10 2-s2.0-73449122976 10.1016/j.neuint.2009.08.008
95. Ufnal M., Sikora M., Dudek M., Exogenous hydrogen sulfide produces hemodynamic effects by triggering central neuroregulatory mechanisms. Acta Neurobiologiae Experimentalis 2008 68 3 382 388 2-s2.0-52949147788
96. Wang M.-J., Cai W.-J., Li N., Ding Y.-J., Chen Y., Zhu Y.-C., The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxidants and Redox Signaling 2010 12 9 1065 1077 2-s2.0-77950796610 10.1089/ars.2009.2945
97. Liu Y.-Y., Bian J.-S., Hydrogen sulfide protects amyloid- β induced cell toxicity in microglia. Journal of Alzheimer's Disease 2010 22 4 1189 1200 2-s2.0-78650489401 10.3233/JAD-2010-101002
98. Kimura Y., Kimura H., Hydrogen sulfide protects neurons from oxidative stress. The FASEB Journal 2004 18 10 1165 1167 2-s2.0-9444263079 10.1096/fj.04-1815fje (Pubitemid 39561558)
99. Tang X.-Q., Shen X.-T., Huang Y.-E., Chen R.-Q., Ren Y.-K., Fang H.-R., Zhuang Y.-Y., Wang C.-Y., Inhibition of endogenous hydrogen sulfide generation is associated with homocysteine-induced neurotoxicity: role of ERK1/2 activation. Journal of Molecular Neuroscience 2011 45 1 60 67 2-s2.0-79960941577 10.1007/s12031-010-9477-z
100. Wang R., Hydrogen sulfide: a new EDRF. Kidney International 2009 76 7 700 704 2-s2.0-70349205750 10.1038/ki.2009.221
101. 2S), an endogenous gas with odor of rotten eggs might be a cardiovascular function regulator. Annales de Cardiologie et d'Angeiologie 2008 57 3 136 138 2-s2.0-46749099324 10.1016/j.ancard.2008.02.014
102. Sodha N. R., Clements R. T., Feng J., Liu Y., Bianchi C., Horvath E. M., Szabo C., Stahl G. L., Sellke F. W., Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. Journal of Thoracic and Cardiovascular Surgery 2009 138 4 977 984 2-s2.0-70349118533 10.1016/j.jtcvs.2008.08.074
103. Kolias A. G., Sen J., Belli A., Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. Journal of Neuroscience Research 2009 87 1 1 11 2-s2.0-63049113042 10.1002/jnr.21823
104. Yu Y.-P., Li Z.-G., Wang D.-Z., Zhan X., Shao J.-H., Hydrogen sulfide as an effective and specific novel therapy for acute carbon monoxide poisoning. Biochemical and Biophysical Research Communications 2011 404 1 6 9 2-s2.0-78650877427 10.1016/j.bbrc.2010.11.113
105. Gong Q.-H., Shi X.-R., Hong Z.-Y., Pan L.-L., Liu X.-H., Zhu Y.-Z., A new hope for neurodegeneration: possible role of hydrogen sulfide. Journal of Alzheimer's Disease 2011 24 2 173 182 2-s2.0-79955657470 10.3233/JAD-2011-110128
106. Ostrowski R. P., Colohan A. R., Zhang J. H., Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurological Research 2006 28 4 399 414 2-s2.0-33745652438 10.1179/016164106X115008 (Pubitemid 43967787)
107. Dumont A. S., Dumont R. J., Chow M. M., Lin C.-L., Calisaneller T., Ley K. F., Kassell N. F., Lee K. S., Barrow D. L., Macdonald R. L., Hoh B. L., Ogilvy C. S., Lawton M. T., Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003 53 1 123 135 2-s2.0-0038725119 (Pubitemid 36801515)